TIAA FSB’s Inovio Pharmaceuticals INO Stock Holding History

TIAA FSB’s Portfolio INO Stock Details INO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	$6.42K	Buy	1,199 +3	+0.3%	+$24	﹤0.01%	572
2023 Q1	$11.8K	Hold	1,196	–	–	﹤0.01%	569
2022 Q4	$22.4K	Hold	1,196	–	–	﹤0.01%	565
2022 Q3	$25K	Hold	1,196	–	–	﹤0.01%	565
2022 Q2	$25K	Buy	+1,196	New	+$33.7K	﹤0.01%	588
2020 Q2	–	Sell	-2,862	Closed	-$256K	–	282
2020 Q1	$256K	Sell	2,862 -7,585	-73%	-$468K	﹤0.01%	261
2019 Q4	$414K	Sell	10,447 -7,287	-41%	-$219K	﹤0.01%	279
2019 Q3	$436K	Hold	17,734	–	–	﹤0.01%	278
2019 Q2	$626K	Buy	+17,734	New	+$705K	﹤0.01%	250

Other funds holding INO

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

TIAA FSB's INO Position: Q2 2023 in Review

TIAA FSB increased its Inovio Pharmaceuticals (INO) stake by 0.25% in Q2 2023, buying an estimated $24 and bringing the position to 1,199 shares worth $6.42K. The position accounts for ﹤0.01% of the portfolio, ranked #572.

TIAA FSB first reported a position in INO in Q2 2019 and has held it in 9 quarters since. The position peaked at $626K in Q2 2019. 133 funds tracked by Wall St. Rank hold INO as of Q2 2023.

TIAA FSB held 1,199 shares of Inovio Pharmaceuticals worth $6.42K as of Q2 2023.
TIAA FSB bought 3 Inovio Pharmaceuticals shares in Q2 2023, an estimated $24.
Inovio Pharmaceuticals made up ﹤0.01% of TIAA FSB's portfolio in Q2 2023, its #572 holding.
TIAA FSB first reported a position in Inovio Pharmaceuticals in Q2 2019 and has held it in 9 quarters since.
TIAA FSB's Inovio Pharmaceuticals position peaked at $626K in Q2 2019.
133 funds tracked by Wall St. Rank held Inovio Pharmaceuticals as of Q2 2023.

Based on TIAA FSB's 13F filing for Q2 2023, filed 31 Jul 2023.